These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19697107)

  • 1. Methods of utilizing baseline values for indirect response models.
    Woo S; Pawaskar D; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2009 Oct; 36(5):381-405. PubMed ID: 19697107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of dosing impact on intra-individual variability in estimation of parameters for basic indirect response models.
    Krzyzanski W; Dmochowski J; Matsushima N; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2006 Oct; 33(5):635-55. PubMed ID: 16941234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches to handling pharmacodynamic baseline responses.
    Dansirikul C; Silber HE; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2008 Jun; 35(3):269-83. PubMed ID: 18446428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-optimal designs for parameter estimation for indirect pharmacodynamic response models.
    Khinkis LA; Krzyzanski W; Jusko WJ; Greco WR
    J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):523-39. PubMed ID: 19904585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation and evaluation of the SAEM algorithm for longitudinal ordered categorical data with an illustration in pharmacokinetics-pharmacodynamics.
    Savic RM; Mentré F; Lavielle M
    AAPS J; 2011 Mar; 13(1):44-53. PubMed ID: 21063925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing multi-response data using forcing functions.
    Zhang L; Sheiner LB
    J Pharmacokinet Pharmacodyn; 2005 Apr; 32(2):283-305. PubMed ID: 16283535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of baseline parameters in determining indirect pharmacodynamic responses.
    Sun YN; Jusko WJ
    J Pharm Sci; 1999 Oct; 88(10):987-90. PubMed ID: 10514344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Handling data below the limit of quantification in mixed effect models.
    Bergstrand M; Karlsson MO
    AAPS J; 2009 Jun; 11(2):371-80. PubMed ID: 19452283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of bias, precision, robustness and runtime for estimation methods in NONMEM 7.
    Johansson ÅM; Ueckert S; Plan EL; Hooker AC; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2014 Jun; 41(3):223-38. PubMed ID: 24801864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models.
    Bulitta JB; Landersdorfer CB
    AAPS J; 2011 Jun; 13(2):212-26. PubMed ID: 21374103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of pharmacokinetic parameters by orthogonal regression: comparison of four algorithms.
    Tod M; Aouimer A; Petitjean O
    Comput Methods Programs Biomed; 2002 Jan; 67(1):13-26. PubMed ID: 11750944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of misspecification of residual error or correlation structure on the type I error rate for covariate inclusion.
    Silber HE; Kjellsson MC; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2009 Feb; 36(1):81-99. PubMed ID: 19219538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two bootstrapping routines for obtaining imprecision estimates for nonparametric parameter distributions in nonlinear mixed effects models.
    Baverel PG; Savic RM; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):63-82. PubMed ID: 21076858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population stochastic modelling (PSM)--an R package for mixed-effects models based on stochastic differential equations.
    Klim S; Mortensen SB; Kristensen NR; Overgaard RV; Madsen H
    Comput Methods Programs Biomed; 2009 Jun; 94(3):279-89. PubMed ID: 19268387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the nonparametric estimation method in NONMEM VI: application to real data.
    Baverel PG; Savic RM; Wilkins JJ; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2009 Aug; 36(4):297-315. PubMed ID: 19572188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of type I error rates for the statistical sub-model in NONMEM.
    Wählby U; Bouw MR; Jonsson EN; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2002 Jun; 29(3):251-69. PubMed ID: 12449498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects.
    Pradhan S; Song B; Lee J; Chae JW; Kim KI; Back HM; Han N; Kwon KI; Yun HY
    BMC Med Res Methodol; 2017 Dec; 17(1):154. PubMed ID: 29191177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of FOCEI and SAEM Estimation Methods in Population Pharmacokinetic Analysis Using NONMEM
    Sukarnjanaset W; Wattanavijitkul T; Jarurattanasirikul S
    Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):729-736. PubMed ID: 29785609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous vs. sequential analysis for population PK/PD data I: best-case performance.
    Zhang L; Beal SL; Sheiner LB
    J Pharmacokinet Pharmacodyn; 2003 Dec; 30(6):387-404. PubMed ID: 15000421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.